PortfoliosLab logoPortfoliosLab logo
ISRG vs. LLY
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

ISRG vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Intuitive Surgical, Inc. (ISRG) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ISRG vs. LLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ISRG
Intuitive Surgical, Inc.
-18.60%8.51%54.72%27.14%-26.15%31.76%38.39%23.43%31.23%72.64%
LLY
Eli Lilly and Company
-14.27%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%

Fundamentals

Market Cap

ISRG:

$166.14B

LLY:

$825.96B

EPS

ISRG:

$7.89

LLY:

$22.96

PE Ratio

ISRG:

58.45

LLY:

40.06

PEG Ratio

ISRG:

3.58

LLY:

0.81

PS Ratio

ISRG:

16.59

LLY:

12.68

PB Ratio

ISRG:

9.32

LLY:

31.13

Total Revenue (TTM)

ISRG:

$10.06B

LLY:

$65.18B

Gross Profit (TTM)

ISRG:

$6.64B

LLY:

$54.62B

EBITDA (TTM)

ISRG:

$3.62B

LLY:

$27.94B

Returns By Period

In the year-to-date period, ISRG achieves a -18.60% return, which is significantly lower than LLY's -14.27% return. Over the past 10 years, ISRG has underperformed LLY with an annualized return of 21.20%, while LLY has yielded a comparatively higher 30.92% annualized return.


ISRG

1D
1.81%
1M
-8.44%
YTD
-18.60%
6M
3.08%
1Y
-6.92%
3Y*
21.74%
5Y*
13.09%
10Y*
21.20%

LLY

1D
3.74%
1M
-12.57%
YTD
-14.27%
6M
20.93%
1Y
12.19%
3Y*
39.90%
5Y*
39.16%
10Y*
30.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ISRG vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ISRG
ISRG Risk / Return Rank: 3232
Overall Rank
ISRG Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
ISRG Sortino Ratio Rank: 2929
Sortino Ratio Rank
ISRG Omega Ratio Rank: 2929
Omega Ratio Rank
ISRG Calmar Ratio Rank: 3434
Calmar Ratio Rank
ISRG Martin Ratio Rank: 3535
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 5151
Overall Rank
LLY Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 4848
Sortino Ratio Rank
LLY Omega Ratio Rank: 4949
Omega Ratio Rank
LLY Calmar Ratio Rank: 5353
Calmar Ratio Rank
LLY Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ISRG vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Intuitive Surgical, Inc. (ISRG) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ISRGLLYDifference

Sharpe ratio

Return per unit of total volatility

-0.21

0.29

-0.49

Sortino ratio

Return per unit of downside risk

-0.08

0.69

-0.76

Omega ratio

Gain probability vs. loss probability

0.99

1.10

-0.10

Calmar ratio

Return relative to maximum drawdown

-0.26

0.42

-0.68

Martin ratio

Return relative to average drawdown

-0.49

1.02

-1.51

ISRG vs. LLY - Sharpe Ratio Comparison

The current ISRG Sharpe Ratio is -0.21, which is lower than the LLY Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of ISRG and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ISRGLLYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.21

0.29

-0.49

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.40

1.23

-0.83

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.66

1.04

-0.38

Sharpe Ratio (All Time)

Calculated using the full available price history

0.49

0.56

-0.07

Correlation

The correlation between ISRG and LLY is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

ISRG vs. LLY - Dividend Comparison

ISRG has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.68%.


TTM20252024202320222021202020192018201720162015
ISRG
Intuitive Surgical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.68%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%

Drawdowns

ISRG vs. LLY - Drawdown Comparison

The maximum ISRG drawdown since its inception was -82.26%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for ISRG and LLY.


Loading graphics...

Drawdown Indicators


ISRGLLYDifference

Max Drawdown

Largest peak-to-trough decline

-82.26%

-68.24%

-14.02%

Max Drawdown (1Y)

Largest decline over 1 year

-24.09%

-30.26%

+6.17%

Max Drawdown (5Y)

Largest decline over 5 years

-49.90%

-34.48%

-15.42%

Max Drawdown (10Y)

Largest decline over 10 years

-49.90%

-34.48%

-15.42%

Current Drawdown

Current decline from peak

-24.48%

-17.00%

-7.48%

Average Drawdown

Average peak-to-trough decline

-21.24%

-19.25%

-1.99%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.78%

12.39%

+0.39%

Volatility

ISRG vs. LLY - Volatility Comparison

The current volatility for Intuitive Surgical, Inc. (ISRG) is 6.47%, while Eli Lilly and Company (LLY) has a volatility of 9.04%. This indicates that ISRG experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ISRGLLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.47%

9.04%

-2.57%

Volatility (6M)

Calculated over the trailing 6-month period

22.11%

26.21%

-4.10%

Volatility (1Y)

Calculated over the trailing 1-year period

33.82%

42.44%

-8.62%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.02%

32.14%

+0.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.10%

29.80%

+2.30%

Financials

ISRG vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Intuitive Surgical, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
2.87B
19.29B
(ISRG) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

ISRG vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Intuitive Surgical, Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

65.0%70.0%75.0%80.0%85.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
66.4%
85.1%
Portfolio components
ISRG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Intuitive Surgical, Inc. reported a gross profit of 1.90B and revenue of 2.87B. Therefore, the gross margin over that period was 66.4%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported a gross profit of 16.41B and revenue of 19.29B. Therefore, the gross margin over that period was 85.1%.

ISRG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Intuitive Surgical, Inc. reported an operating income of 864.30M and revenue of 2.87B, resulting in an operating margin of 30.2%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported an operating income of 8.78B and revenue of 19.29B, resulting in an operating margin of 45.5%.

ISRG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Intuitive Surgical, Inc. reported a net income of 794.80M and revenue of 2.87B, resulting in a net margin of 27.7%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported a net income of 6.64B and revenue of 19.29B, resulting in a net margin of 34.4%.